Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1007757

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Levetiracetam
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of the UK leaving the EU on the availability of Keppra for people with epilepsy.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	191984
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The United Kingdom’s position on medicines regulation remains clear. We want to retain a close working partnership with the European Union to ensure that medicines remain available to UK patients in a safe and timely manner. We have been clear that this involves us making sure our regulators continue to work together, as they do with regulators internationally. As the Prime Minister has said, we intend to to explore with the EU the terms on which the UK could remain part the European Medicines Agency.</p><p> </p><p>Until we can be certain of the outcome of Brexit negotiations our duty as a responsible Government is to prepare for all eventualities, including ‘no deal’. On 23 August 2018, therefore, the Department wrote to all pharmaceutical companies that supply the United Kingdom with prescription only or pharmacy medicines from, or via, the European Union/European Economic Area, asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no-deal scenario.</p><p> </p><p>Since then, we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a no-deal Brexit.</p><p> </p><p>We understand that the medicine Keppra is important to many people in this country. However, the Department recognises that through its medicines supply contingency programme it is requesting sensitive commercial information from pharmaceutical companies. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company, specific medicine or their supply routes into the public domain.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 11:54:10 answering member 4067 label Biography information for Steve Brine
tabling member	4648 label Biography information for Laura Smith

1007767

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nusinersen
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress NHS England, Biogen and NICE have made in discussions on a managed access agreement for the use of Spinraza for the treatment of spinal muscular dystrophy.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	191928
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance for the National Health Service on the use of Spinraza (nusinersen) for the treatment of spinal muscular atrophy (SMA).</p><p> </p><p>NICE is in discussion with Biogen (the company that manufactures Spinraza) to determine if there are any commercial flexibilities that could support the company in putting forward a cost-effective price in order for NICE to recommend use of the drug as a clinically and cost-effective use of NHS resources.</p><p> </p><p>NHS England has published an Interim Policy Statement determining the circumstances in which existing patients will be supported to access Spinraza through the Expanded Access Programme (EAP) scheme sponsored by Biogen. The policy statement enables existing patients with type 1 SMA to access Spinraza in advance of NICE’s guidance, although the company has now withdrawn the EAP for newly diagnosed patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 15:13:09 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

1007777

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will introduce a secondary support package covering breast cancer care to include (a) access to a dedicated clinical nurse specialist, (b) an assessment of physical and emotional needs at (i) diagnosis and (ii) through treatment and referral and (c) signposting to tailored, specialist support services.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	191871
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The NHS Cancer Programme is working to improve access to cancer nurse specialists (CNSs) for all cancer patients when they need it, including those with secondary breast cancer.</p><p> </p><p>We are committed to rolling out the recovery package to every cancer patient by 2020. The recovery package is a set of four interventions designed to help patients and clinicians assess a patient’s holistic needs, including physical and emotional needs, at appropriate time points through their cancer journey, as needs do change especially when a person is diagnosed with secondary cancer. A personalised care and support plan to meets these needs should be agreed, ensuring signposting and referral to the right support and care services is made, and also helping to empower patients to independently manage their own health, with advice and support.</p><p> </p><p>NHS England is committed to giving more patients access to a CNS or other specialist from diagnosis onwards to guide them through treatment options and ensure they receive appropriate information and support. In their first Cancer Workforce Plan, which was published in December 2017, Health Education England committed to supporting the expansion of CNSs by developing national competencies and a clear route into training. This will ensure that every patient has access to a CNS or other support worker by 2021.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 15:20:10 answering member 4067 label Biography information for Steve Brine
tabling member	478 label Biography information for Lord Field of Birkenhead

1007778

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Suicide: LGBT+ People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the suicide prevention strategy addresses the needs of LGBT people.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	191933
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>In July 2018, the Government Equalities Office published a report titled ‘Improving LGBT lives: Government action since 2010’ which is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/improving-lgbt-lives-government-action-since-2010" target="_blank">https://www.gov.uk/government/publications/improving-lgbt-lives-government-action-since-2010</a></p><p> </p><p>That report made a commitment that the Government will take action to improve mental healthcare for LGBT people and, as part of this, the Department will work with the Government Equalities Office to implement elements of its LGBT Action Plan through the National Suicide Prevention Strategy. We will set this work out in a Cross-Government Suicide Prevention Workplan which will be published shortly.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 23/11/2018 11:25:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4267 label Biography information for Sarah Champion

1007779

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: LGBT+ People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking with (a) medical and nursing schools, (b) the Royal College of Psychiatrists, (c) the British Psychological Society and (d) mental health training providers to ensure that their (i) curricula, (ii) standards and (iii) compulsory and ongoing training include the mental health needs of LGBT people.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	191934
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>It is the responsibility of the General Medical Council and the Nursing and Midwifery Council, in setting the outcomes that medical and nursing students need to achieve through their training, to ensure it is reflective of the knowledge and experience needed to support and advise the patients they see.</p><p> </p><p>Health Education England (HEE) has responsibility for ensuring the NHS in England has the workforce it requires in the right numbers, in the right place and with the right skills. HEE, together with regulators and Royal Colleges, ensures undergraduate and post graduate curriculum meets the needs of all patients.</p><p> </p><p>HEE are also working with stakeholders to support the awareness raising of the mental health needs of the LGBT community. HEE’s competency frameworks, published on 10 October, on suicide recognised that the LGBT community are a high-risk group and there is need for specific suicide prevention interventions to be targeted at this group of people.</p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 23/11/2018 14:17:16 answering member 1585 label Biography information for Stephen Hammond
tabling member	4267 label Biography information for Sarah Champion

1007780

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: LGBT+ People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference Stonewall's report entitled LGBT in Britain: Health Report, published in November 2018, if he will ask NHS England to run a national campaign to (a) tackle (i) homophobic, (ii) biphobic and (iii) transphobic discrimination in healthcare services and (b) encourage reporting of such discrimination.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	191935
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The Government has no plans to run such a national campaign at this time. The Department is working closely with NHS England and the Government Equalities Office in the implementation of the LGBT Action Plan, which was published in July 2018. This will include the recruitment of a National Adviser who will work to lead improvements to LGBT healthcare.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 22/11/2018 11:50:59 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4267 label Biography information for Sarah Champion

1007786

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Parkinson's Disease: Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people with Parkinson’s disease accessed Improving Access to Psychological Therapies services; what the average waiting time was for a person with Parkinson’s disease from referral to first appointment; and what the recovery rate was for people with Parkinson’s disease following completion of that treatment in 2016-17.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	191900
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>This information is not held centrally.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 23/11/2018 11:19:12 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3957 label Biography information for Martin Vickers

1007787

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Parkinson's Disease: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much the National Institute of Health Research spent on research into mental health interventions for people with Parkinson’s disease who have anxiety and/or depression in each of the five years up to and including 2017.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	191901
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including Parkinson’s disease and related illness. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>The following table shows NIHR research into mental health interventions for people with Parkinson’s disease who suffer anxiety and or depression over the last five years is approximately £4.9 million. This includes funding for research projects and clinical trials through the NIHR Clinical Research Network:</p><p> </p><table><tbody><tr><td><p>Financial Year (FY) 2013/14</p></td><td><p>FY 2014/15</p></td><td><p>FY 2015/16</p></td><td><p>FY 2016/17</p></td><td><p>FY 2017/18</p></td><td><p>Total</p></td></tr><tr><td><p>69,386</p></td><td><p>993,419</p></td><td><p>1,107,936</p></td><td><p>1,392,344</p></td><td><p>1,393,003</p></td><td><p>4,956,090</p></td></tr></tbody></table> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/11/2018 12:14:05 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	3957 label Biography information for Martin Vickers

1007788

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many prescription items were dispensed for free in each exemption category in the last period for which figures are available.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	191902
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The information is not held in the format requested.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 15:11:14 answering member 4067 label Biography information for Steve Brine
tabling member	3957 label Biography information for Martin Vickers

1007816

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Compulsorily Detained Psychiatric Patients: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the Independent Review of the Mental Health Act on the rate of detentions under the Mental Health Act 1983 in Birmingham and Solihull Clinical Commissioning Group.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	191976
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>The Independent Review of the Mental Health Act will report before the end of the year. The Government will consider its findings and respond in due course. The Review will make recommendations to Government for how it should improve the Act, including considering what changes might be needed to reduce the number of detentions under the Act, but the Review itself was not commissioned to have a direct influence on legislation or practice.</p><p> </p><p>We have therefore made no assessment on the effect of the Independent Review of the Mental Health Act on the rate of detentions under the Mental Health Act 1983.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 191977 192127 question first answered 23/11/2018 11:17:27 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4603 label Biography information for Preet Kaur Gill